Company Data
Talphera Inc.
Ticker
TLPH
Current Price
$0.624 -6.87%
Market Cap
$10.6M
Price Target
Refer to Report
Volume
68.8K
52wk Range
$0.501 - $1.61
Overview
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company’s products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.